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Abstract
The ecdysone receptor is a heterodimer of two nuclear receptors, the Ecdysone receptor (EcR) and Ultraspiracle (USP). In
Drosophila melanogaster, three EcR isoforms share common DNA and ligand-binding domains, but these proteins differ in
their most N-terminal regions and, consequently, in the activation domains (AF1s) contained therein. The transcriptional
coactivators for these domains, which impart unique transcriptional regulatory properties to the EcR isoforms, are unknown.
Activating transcription factor 4 (ATF4) is a basic-leucine zipper transcription factor that plays a central role in the stress
response of mammals. Here we show that Cryptocephal (CRC), the Drosophila homolog of ATF4, is an ecdysone receptor
coactivator that is specific for isoform B2. CRC interacts with EcR-B2 to promote ecdysone-dependent expression of ecdysis-
triggering hormone (ETH), an essential regulator of insect molting behavior. We propose that this interaction explains some
of the differences in transcriptional properties that are displayed by the EcR isoforms, and similar interactions may underlie
the differential activities of other nuclear receptors with distinct AF1-coactivators.
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Introduction
Nuclear receptors are multifunctional transcription factors that
mediate responses to steroids and other small hydrophobic
signaling molecules. Most nuclear receptors have two transcrip-
tional activation functions (AF1 and AF2). AF2 is formed by
ligand-induced folding of the ligand-binding domain, and the
structural basis of its interaction with coactivators is becoming
known. AF1 designates a second, ligand-independent activation
function often present in the N-terminal region of the receptor.
AF1 sequences are not conserved, and the existence of an AF1
must be inferred from functional assays. Although the AF1s are of
considerable interest, because they often differentiate receptor
isoforms and because some have been shown to interact with
general transcription factors, comparatively few AF1-coactivator
interactions have been characterized. The relative contributions of
AF1 and AF2 to transcriptional activation vary among receptors,
and for any given receptor the relative contributions may depend
upon the promoter context [1].
The three isoforms of EcR (FlyBase ID: FBgn0000546) have
unrelated AF1 regions, each capable of mediating transcriptional
activation in some contexts [2–6]. Although several coactivators
and corepressors for the AF2 of EcR have been identified [7–13],
the interacting factors for the unique AF1 domains remain
unknown. The 17-residue AF1 region of isoform B2 is capable of
strong transcriptional activation on a standard test promoter and is
required for ecdysone-regulated differentiation in a few fly tissues
[2,4]. Here, we show that the bZIP transcription factor, CRC
(FBgn0000370), binds the AF1 of isoform B2 to promote steroid-
dependent expression of the peptide molting hormone, ETH
(FBgn0028738; [14]).
Results
The AF1 of EcR-B2 Bound to the Leucine Zipper of CRC
We performed a yeast two-hybrid screen using the N-terminal
region of EcR-B2 as bait and recovered a plasmid containing the
complete coding sequence of the predominant CRC isoform,
CRC-A [15]. Figure 1 illustrates the salient features of these
assays. Interaction (as judged by reporter activation) required the
presence of both CRC-A and the AF1 of EcR-B2 (Figure 1A).
The EcR-B2 mutation E9K, which sharply reduces transcrip-
tional activation in vivo [4], also abolished the two-hybrid
interaction (Figure 1A). The interaction surface provided by
CRC was contained within the C-terminal three-quarters of the
protein, a region that includes its bZIP and PEST domains, and
C-terminal truncation of the protein to remove just the leucine
zipper domain abolished the interaction with EcR-B2
(Figure 1B).
Binding of CRC to the amino-terminal region of EcR-B2 was
confirmed in vitro (Figure 2A). Radiolabeled CRC-A bound to the
EcR-B2 amino-terminus and to full-length EcR-B2, but not to
EcR-B1 or to EcR-B2 carrying the E9K mutation. The AF1
region of the EcR-B2 N-terminus contains sequences suggestive
of a short amphipathic helix, and it is known that the acidic-to-
basic substitution E9K (within the proposed helix) abolishes AF1
function in vivo [4]. We think it likely that this helix is
unstructured in solution and infer that both ionic and hydropho-
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bic interactions play roles in its dimerization, probably with the
leucine zipper region of CRC. To test this idea further, we made
several individual basic-to-acidic mutations within the CRC
leucine zipper – at sites predicted to determine the dimerization
specificity of the bZIP domain [16] – and tested the binding of
the mutant CRC proteins to wild-type and E9K mutant EcR-B2
(Figure 2B). The binding properties of CRC-R347E and CRC-
R353E were indistinguishable from those of wild-type CRC, but
CRC-R361E bound EcR-B2-E9K. That an alteration in CRC
reversed the effect of an EcR mutation strongly implies direct
interaction.
Neither USP (FBgn0003964) nor the hormone ecdysone
affected the CRC-EcR-B2 interaction as measured in our
biochemical tests (Figure 2A). While AF1 activity is hormone-
dependent in vivo, that is probably due to the effects of corepressors
(e.g. SMRTER) that bind unliganded EcR/USP and suppress the
activity of AF1 [4].
Loss of CRC Enhanced Phenotypes in Tissues Requiring
EcR-B2
Both the crc mutant phenotype, which includes molting defects
that result in supernumerary mouthparts in larvae and failure to
evert the adult head at pupal ecdysis, and the pattern of crc
expression suggest a role for CRC in the ecdysone response [15].
We used a genetic interaction test to determine whether CRC
functions as a modulator of EcR-B2 function in flies. We
examined the effects of a single copy of crc1 (a spontaneous
mutation, Q171R; FBal0001818) [15,17] on the phenotype
produced by targeted expression of the dominant-negative
mutant EcR-B1-F645A [2,4]. EcR-B1-F645A is normal in
transcriptional repression (the effect of unliganded receptor),
but it fails to mediate transcriptional activation. Because the EcR
isoforms do not display isoform specificity in DNA binding [5],
the EcR-B1-F645A mutant is thought to competitively inhibit all
three endogenous EcR isoforms [18]. Hence, a reduction in EcR-
B2 coactivator titer should selectively enhance the effects caused
by EcR-F645A expression only in tissues requiring the EcR-B2
isoform.
Targeted expression of the dominant-negative receptor EcR-
B1-F645A permits an examination of the properties of EcR
function in specific tissues in the context of an otherwise normal
animal [2]. crc1 is a recessive mutation, and crc1/crc+ heterozygous
cells are phenotypically normal. We generated sensitized tissues
by targeting expression of EcR-B1-F645A to five different
developmental domains, using specific GAL4 drivers [2]. As
shown in Table 1, crc1 was a dominant enhancer of the EcR
dominant negative phenotype in the Eip domain (largely larval
epidermis) and in the slbo domain (specialized portions of the
follicular epithelium of the egg chamber), but it had no significant
effect in the GMR domain (primarily retinal epithelium), the dpp
domain (primarily A/P disc boundaries), or the Lsp2 domain (fat
body). We have previously described the EcR isoform require-
ments in each of these domains [2]. There was a remarkable
Figure 1. Interaction of the EcR-B2 N-terminus with CRC in
yeast two-hybrid assay. (A) In yeast two-hybrid assays, activation of
a UAS-lacZ reporter (reporter activity) required the presence of both
EcR-B2 and CRC-A. This interaction was abolished by the EcR-B2
mutation E9K. In these assays, a fusion of the GAL4 DNA-binding
domain to either the 17-residue AF1 domain of EcR-B2 (black bars), or
the same fragment containing the mutation E9K (gray bars) served as
bait. Full length CRC-A was used as the prey. Error bars indicate
standard deviations for 4 independent assays. (B) The indicated CRC
residues were substituted for full-length CRC-A and tested for binding
to the wild-type EcR-B2 fusion fragment in yeast two-hybrid assays.
Coordinates of the conserved domains of CRC are indicated in the
drawing below.
doi:10.1371/journal.pgen.1002883.g001
Author Summary
Nuclear receptors are proteins that regulate gene expres-
sion in response to steroid and thyroid hormones and
other small lipid-soluble signaling molecules. In many
cases, nuclear receptor genes encode multiple variants
(isoforms) that direct tissue- and stage-specific hormonal
responses. The sequence differences among isoforms are
often found at the protein N-terminus, which mediates
hormone-independent interactions with unknown regula-
tory partners to control target gene expression. Here, we
show that the fruit fly Cryptocephal (CRC) protein is a
specific coactivator for one of three isoforms of the
receptor for the insect molting steroid, ecdysone. Our
findings reveal a mechanism for differential activation of
gene expression in response to ecdysone during insect
molting and metamorphosis, and contribute to our
understanding of isoform-specific functions of nuclear
hormone receptors.
CRC Is an EcR-B2 Coactivator
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correlation: Where EcR-B2 is required for development, wild-
type crc function was also required, and where normal develop-
ment does not require EcR-B2, reduction of the CRC titer had
little or no effect.
CRC Regulation of ETH Expression
In homozygous or hemizygous crc1 mutant larvae, expression of
ETH is markedly reduced [19]. The loss of crc has similar effects
on expression of an ETH-EGFP reporter gene, which contains
Figure 2. Binding of CRC to EcR-B2 in vitro. (A) CRC-A bound in vitro to the 17 amino acid amino-terminus of EcR-B2 and full length EcR-B2, but
not to EcR-B1 or EcR-B2-E9K. This interaction was not dependent upon USP or ecdysone. Gels from two experiments are shown; the labeled protein
was 35S-GAD-CRC-A in the left gel, 35S-CRC-A in the right gel. Lanes labeled ‘‘input’’ contained 100% of the input labeled protein. The remaining
samples contained the EcR or EcR fragment shown above, and other components as indicated. GBT-B2-NS is a fusion of the DNA-binding domain of
GAL4 with the amino-terminal 17 amino acids of EcR-B2. In lanes labeled B2-E9K, E9K mutant EcR-B2 or E9K mutant GBT-B2-NS was substituted 1:1 for
the corresponding wild-type protein. Full-length EcRs were precipitated with a mixture of two EcR-common region monoclonal antibodies, and GBT-
B2-NS was precipitated with an antibody to the GAL4 DNA-binding domain. (B) A similar experiment, showing the binding of wild-type and mutant
CRCs to full-length EcR-B2. Each incubation mixture contained the 35S-radiolabeled CRC protein listed above and the other components listed below,
and precipitations were performed with the same mix of EcR common region antibodies as in (A). Wild-type CRC, CRC-R347E, and CRC-R353E bound
to EcR-B2 but not EcR-B2-E9K. However, the basic-to-acidic mutation in CRC-R361E permitted binding to EcR-B2-E9K.
doi:10.1371/journal.pgen.1002883.g002
Table 1. Dominant effects of crc1 on the phenotypes of EcR-B1-F645A expression.
% Survival
Driver (temperature) crc+/crc+ crc1/crc+ Ratio heterozygote/wild-type
Effect of crc1 on EcR-
F645A phenotype
EcR isoform
requirement
GMR (20u) 4.7 (21) 5.5 (40) 1.2 none any
dpp (20u) 4.2 (33) 8.5 (72) 2.0 slight suppression any
Lsp2 (25u) 3.7 (12) 9.5 (25) 2.6 slight suppression any
Eip (16u) 5.1 (15) 1.0 (13) 0.27 enhancement B2
slbo (25u) qualitative assay enhancement B2
All flies contained, in addition to the indicated crc genotype, one copy of UAS-EcR-B1-F645A and one copy of the indicated driver. Quantitative data represent % viability
to adult eclosion for the indicated genotype; the nature of the lethality in each case is described elsewhere [5]. Effects of EcR-B1-F645A in the slbo domain were
assessed qualitatively by observing the tendency of eggs laid by an affected female to collapse. Each datum was produced by crossing a driver stock to either UAS-EcR-
B1-F645A/CyO (crc+/crc+) or UAS-EcR-B1-F645A crc1/CyO (crc1/crc+). Survival was determined by comparing the number of adults recovered which carry the UAS-EcR-B1-
F645A-containing chromosome with the number of adults carrying the CyO balancer; the number in parentheses indicates the number of EcR-B1-F645A-expressing
adults recovered. In a control experiment to determine the relative strength of transgene expression in each domain, the Gal4 drivers were crossed to UAS-nuclear-GFP
(FBti0012492), the tissues were fixed in 4% paraformaldehyde and washed, and the intensity of direct GFP fluorescence in single confocal sections (signal - background)
was quantified. The mean intensities of GFP fluorescence were: dpp (FBti0002123) 71.6+/29.6, GMR (FBti0002994) 59.3+/26.3, slbo (FBti0023075) 50.9+/29.4, Eip
(FBtp0016770) 30.6+/24.3, Lsp2 (FBti0018531) 25.8+/24.8 (+/2 SEM, n = 6). Thus, the intensity of driver expression was not correlated with the ability to enhance the
EcR dominant negative phenotype.
doi:10.1371/journal.pgen.1002883.t001
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382 bp of the ETH promoter and precisely recapitulates the native
pattern of ETH expression [14,19]. Thus, CRC up-regulates ETH
expression.
CRC is expressed in many larval tissues, including the
endocrine source of ecdysone [15]. Therefore, to test for cell-
autonomous regulation of ETH expression by CRC, we used an
ETH-GeneSwitch driver to drive transgenic crc RNAi (UAS-crc-RNAi)
specifically in the Inka cells (Figure S1), the site of ETH synthesis
[14]. GeneSwitch is a conditional GAL4 protein that is activated
by addition of the progesterone antagonist RU486 to the food
[20]. Compared to the control larvae, larvae with crc RNAi
showed a 15-fold or greater reduction in ETH transcript levels
(Figure 3A). Thus, CRC was cell-autonomously required in the
Inka cells for full ETH expression.
Regulation of ETH Expression by Ecdysone
The Drosophila melanogaster ETH promoter contains a putative
ecdysone response element [19,21], and ETH expression in the
tobacco hawkmoth (Manduca sexta) fluctuates during the molts and
is elevated in response to circulating ecdysteroids [22]. Therefore,
we examined whether ETH expression is ecdysone-dependent. In
larval and pupal Drosophila, expression of the ETH peptide
hormone is restricted to 14 endocrine Inka cells located on the
trachea [14]. We performed ETH in situ hybridization and found
that ETH transcript levels increased gradually during the first few
hours after metamorphosis was initiated (Figure 4A). The ETH
transcript levels peaked 6–8 hr after the pulse of ecdysone that
occurs at pupariation (Figure 4A), suggesting that ETH was
transcribed in response to elevation of the circulating ecdysone
titer.
We tested for direct ecdysone-dependence of ETH expression in
young third instar stage larvae, when circulating ecdysone and
ETH transcript and protein levels are low, by feeding them the
major active form of ecdysone, 20-hydroxyecdysone (20E) [23].
These larvae carried the ETH-EGFP reporter gene. By 12 hr after
the onset of the 20E treatment, the level of ETH-EGFP
fluorescence was markedly elevated (Figure 4B). Thus, ETH
expression was strongly up-regulated by circulating ecdysone.
To test for a direct, cell autonomous effect of ecdysone on ETH
expression, we targeted EcR-F645A dominant negative proteins
specifically to the Inka cells with the ETH-GeneSwitch driver.
Following Inka cell expression of the EcR dominant negative
proteins, ETH transcripts were still present but at levels that were
2–6 fold lower than in wild-type larvae (Figure 3B). Thus, ETH
expression was strongly stimulated by ecdysone and required EcR
expression in the Inka cells.
CRC and EcR-B2 Interacted to Boost ETH Expression In
Vivo
The EcR-B1-F645A mutant is effective as a dominant negative
when it is expressed in excess of the wild-type isoforms (Table 1)
[2,4]. However, the dominant negative EcR-B1-F645A protein
competes poorly with wild-type EcR when both are expressed
from identical promoters [2,4]. Therefore, to determine which
EcR isoforms support up-regulation of ETH expression in the Inka
cells, we performed competition experiments in which EcR-B1-
F645A and individual wild-type isoforms were coexpressed under
the control of the ETH-GeneSwitch driver. The ability of a wild-type
EcR isoform to mitigate the effects of the dominant negative is
indirect evidence in support of transcriptional activation of the
ETH promoter by that isoform.
Supernumerary mouthparts result when larvae fail to complete
ecdysis to either the second or the third larval instar, and they are
a characteristic feature of the ETH and crc mutant phenotypes
[14,15]. Over 95% of larvae with Inka cell-targeted EcR-B1-
F645A expression had multiple mouthparts, and ,70% of these
animals died as larvae (Figure 5A). Simultaneous expression of
wild-type EcR-B2 or EcR-B2-E9K with EcR-B1-F645A fully
Figure 3. EcR-B1, EcR-B2, and CRC regulated ETH expression. (A) Inka cell-specific crc RNAi lowered ETH transcript levels (n = 9, crc RNAi; n = 6,
ETH-GSW.+controls). *, p,0.05; **, p,0.01 (One-way ANOVA: TM5, p = 0.01225; TM8, p = 0.001375). (B) Inka cell-specific expression of dominant
negative EcR-B1-W650A or EcR-B2-W650A (EcR-B1 DN or EcR-B2 DN) lowered ETH transcript levels (n = 9, dominant negatives; n = 23, Oregon R
controls). **, p,0.01; ***, p,0.001 [One-way ANOVA with Bonferroni (all-pairwise) multiple comparison test: TM5, p = 0.000265; TM8, p= 0.000044].
Bar = 20 mM.
doi:10.1371/journal.pgen.1002883.g003
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rescued lethality and ecdysis of the larval mouthparts, whereas
EcR-B1 and EcR-A produced only partial rescue (Figure 5A).
Within the Inka cells, ETH transcript levels were fully rescued by
EcR-B2, but EcR-B1 and EcR-B2-E9K were ineffective at rescue
(Figure 5B). Thus, of the three EcR isoforms, only wild-type EcR-
B2 was capable of supporting full ETH expression and successful
ecdysis. The E9K mutant of EcR-B2 failed to rescue ETH
transcript levels, suggesting a model in which dimerization of EcR-
B2 with CRC is required for ETH mRNA expression.
In M. sexta, 20E regulates ETH synthesis as well as the
competency of the Inka cells to secrete ETH [24]. The ability of
EcR-B2-E9K, and to a lesser extent EcR-B1 and EcR-A, to rescue
ecdysis and lethality (Figure 5A) indicates that EcR likely regulates
other Inka cell processes, such as ETH protein accumulation or
secretory competence, that are necessary for signaling by ETH.
We tested this hypothesis by performing ETH immunostaining in
EcR-B2-E9K rescue animals both before and after secretion at
pupal ecdysis. Although EcR-B2-E9K did not stimulate ETH
transcription (Figure 5B), it drove ETH protein accumulation in
the Inka cells (Figure S2A). Consistent with the predicted role of
EcR in the development of secretory competence, we also
observed a marked decrease in accumulated ETH at pupal
ecdysis (Figure S2B). These results show that EcR—likely through
different sets of EcR isoforms and transcriptional coactivators—
regulates ETH protein accumulation independently of ETH
mRNA expression.
Discussion
Our experiments suggest that the 17-residue B2-specific N-
terminus binds to the bZIP region of CRC, that an ionic
interaction between EcR-B2-E9 and CRC-R361 plays some role
in the binding, and that the interaction of the two proteins plays a
crucial role in those tissues where EcR-B2 is essential. These
tissues include the endocrine Inka cells, which display ecdysone-
dependent upregulation of ETH transcripts and which require
EcR-B2 and CRC for full ETH expression. Taken together, these
findings implicate CRC as an isoform-specific transcriptional
activator for EcR-B2.
In diverse systems, bZIP proteins interact with dyadic or
palindromic promoter sequences as homodimers or heterodimers
with other bZIP partners [25]. Dimerization involves regularly
spaced hydrophobic amino acids that form a coiled-coil between
two leucine zipper domains [26]. Other bZIP transcription factors
are known to interact with nuclear receptors, modulating the
activities of either AF1 or AF2 [27–29], but in the cases reported
previously, bZIP proteins bind either to the DNA-binding domain
or to the hinge domain of the nuclear receptor. By contrast, CRC
(through its bZIP domain) appears to bind directly to the EcR-B2
AF1 region, and its interaction is specific to one EcR isoform.
ATF4, the mammalian homolog of CRC, plays a central role in
stress responses [30]. The role of CRC in ecdysone signaling
suggests the possibility of interesting and unexpected connections
between stress responses and the control of developmental timing
and metamorphosis.
The ETH promoter contains sequences matching the consensus
half-sites for binding of ATF4 and EcR to DNA. These half-sites
are separated by 4 nucleotides, and they are located within a
highly conserved sequence (comparing D. melanogaster to several
other Drosophila species) that is 138–171 nucleotides upstream of
the ETH transcriptional start site [19]. Since bZIP proteins may
bind first sequentially as monomers and then dimerize while
bound to DNA [26,31], these observations suggest a model in
which CRC participates in the stabilization of EcR-B2 binding to
the ETH promoter. This interaction provides a basis for
understanding some of the differences in transcriptional properties
Figure 4. ETH expression was stimulated by ecdysone. (A) ETH transcript levels mirrored the changes in the circulating ecdysone titer with a 6.5
to 8 hr delay. Transcript levels were measured semi-quantitatively in as the intensity of ETH in situ hybridization in Inka cells in tracheal metamere 5
(TM5) and TM8 at five times at the onset of metamorphosis (relative to pupariation). The arrow indicates the peak of the late-larval pulse of circulating
20E, which occurs at pupariation [23]. Means with the same lower case (TM5) or upper case (TM8) letters were not significantly different [p.0.05,
n = 5–8; One-way ANOVA (TM5, p= 0.000776; TM8, p,0.000001) with Bonferroni (all-pairwise) multiple comparison test]. Insets below the histograms
in (A) and (B) show representative images of cells at each time point. (B) The Inka cells of young third instar larvae fed with 20E for 12 hr showed
higher expression levels for the fluorescent ETH reporter, ETH-EGFP (n = 4). *, p,0.05 (one-way ANOVA: TM5, p = 0.036; TM8, p = 0.044). Bar = 20 mM.
doi:10.1371/journal.pgen.1002883.g004
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that are displayed by the EcR isoforms and perhaps other nuclear
receptors with distinct AF1-coactivators.
Materials and Methods
Yeast Two-Hybrid Screening
Yeast two-hybrid assays were carried out using the Clontech
Matchmaker yeast two-hybrid kit (Clontech, Mountain View, CA)
and yeast strain Hf7C. The bait was a fusion of the GAL4 DNA-
binding domain to either the 17-residue AF1 domain of EcR-B2,
or the same fragment containing the mutation E9K. Binding was
assayed as expression of b-galactosidase from a UAS-lacZ reporter.
In Vitro Protein Binding
Proteins were synthesized in vitro using the TNT reticulocyte
lysate kit (Promega, Madison, WI); template plasmids were
described previously or were generated by a similar procedure
[4]. Binding reactions (50 ml) contained 3 ml of each indicated
translation mix in buffer A (20 mM NaH2PO4, 150 mM NaCl,
pH 8.0) were incubated at 4u for 30 min. Then, 25 ml of a 50%
slurry of Sepharose-protein A (Sigma) loaded with the indicated
antibody was added and the incubation continued for 30 min.
Beads were washed 3 times in buffer A and then boiled in SDS-
PAGE sample buffer. The eluted proteins were separated by SDS-
PAGE and radiolabeled proteins detected by autoradiography.
For precipitation of full length EcRs, a mixture of the EcR-
common region monoclonal antibodies, AG 10.2 and DDA 2.7
[6], was used with each at a 1:10,000 dilution of an ascites fluid.
For precipitation of GBT-B2-NS, we used a commercial antibody
to the GAL4 DNA-binding domain (1:1000, Santa Cruz
Biotechnology, Santa Cruz, CA).
Animals and Staging
Drosophila melanogaster were reared on standard cornmeal-yeast-
agar media at 22–25u unless otherwise noted. Oregon-R was used
as the wild-type strain. Larvae at the onset of metamorphosis were
scored based on the blue color intensity observed in the gut of
third instar larvae fed with cornmeal-yeast-agar food supplement-
ed with 0.1% bromophenol blue. We collected blue gut larvae
(18 hours before pupariation) and clear gut larvae (4 hours before
pupariation) [32]. Prepupae and pupae were selected based on the
criteria reported by Bainbridge and Bownes [33] at the following
stages: white puparium (P1 stage; at puparium formation), buoyant
prepupa (P4i stage; 6.5–8 hours after puparium formation), and
moving bubble prepupa (P4ii stage; 12–13.5 hours after puparium
formation).
The ETH-GeneSwitch (ETH-GSW) line was a kind gift from
Michael Adams (University of California, Riverside) and Yoon-
seung Park (Kansas State University). It expresses a conditional,
RU486-dependent GAL4 protein chimera [20] under the control
of the 382 bp ETH promoter region [19,21]. First instar larvae
carrying ETH-GSW and selected UAS constructs were transferred
after hatching to cornmeal-yeast-agar media supplemented with
500 mM RU486 [34]. In larvae, the expression of a reporter gene
under ETH-GSW/RU486 control was restricted to just the Inka
cells (Figure S1).
The CRC and EcR loss-of-function transgenes included UAS-
Crc-RNAi (Vienna Drosophila RNAi Center (VDRC) line #2935,
FBti0084038) [35], UAS-EcR-B1-W650A (FBti0026963), UAS-EcR-
B2-W650A, UAS-EcR-B1-F645A (FBti0026961), and UAS-EcR-B2-
E9K. The UAS-EcR-B1 (FBti0023086), UAS-EcR-B2 (FBti0023085),
and UAS-EcR-A (FBti0023087) transgenes contain the three wild-
type EcR isoforms [2].
20E Feeding
Freshly ecdysed ETH-EGFP (FBal0136020) third instar larvae
were transferred on cornmeal-yeast-agar media supplemented
with 0.08 mg/ml 20E [36] and collected 12 hours later for
analysis of EGFP fluorescence in the Inka cells.
Tissue Preparation and Image Analysis
Digoxigenin-labeled DNA probe preparation, whole-mount
larval in situ hybridization, ETH in situ hybridization, anti-PETH
Figure 5. EcR-B2 rescued ecdysis and ETH expression following
targeted expression of dominant negative EcR. (A) Ecdysis in
third instar larvae expressing dominant negative EcR-B1-F645A only in
the Inka cells (n = 98; EcR-B1 DN) was rescued by expression of EcR-B2
(n = 165) or EcR-B2-E9K (n = 143), but not by expression of EcR-B1
(n = 91) or EcR-A (n = 59). The controls had ETH-GSW only (n = 148), and
all larvae were fed RU486. The larval counts included all live third instar
larvae (with or without multiple mouthparts), as well as all dead larvae
(of all stages). All of the dead larvae found had multiple mouthparts. (B)
ETH expression in Inka cells expressing dominant negative EcR-B1-
F645A isoform (n = 11) was rescued by co-expression of wild-type EcR-
B2 (n = 8) but not wild-type EcR-B1 (n = 9) or the E9K mutant of EcR-B2
(n = 8). The controls had ETH-GSW only (n = 8), and all larvae were fed
RU486. All larvae were dissected at ,12 hr after ecdysis to the third
instar. Means with the same lower case (TM5) or upper case (TM8)
letters were not significantly different [p.0.05, One-way ANOVA (TM5,
p,0.000001; TM8, p = 0.000002) with Bonferroni (all-pairwise) multiple
comparison test].
doi:10.1371/journal.pgen.1002883.g005
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immunostaining, and ETH-EGFP imaging was performed as
described [19]. In larvae, the Inka cells are identified by the
tracheal metameres (TMs) on which they are located, and the
TMs are numbered 1 to 10, starting with the anterior end of the
animal. To quantify the intensity of EGFP, immunostaining, and
in situ hybridization signals, we measured the Intensity Index*Ar-
ea = S*[(I–B)/B] where (S) is the surface area covered by the
signal, (I) is the mean pixel intensity of the signal within this area,
and (B) is the background signal intensity [19,37]. This method
takes into consideration the density of the signal distributed over
the cell area, and it therefore normalizes for the angle at which the
Inka cell is photographed and for heterogeneity in the spatial
distribution of the signal. The measurements were taken using
Adobe Photoshop (San Jose, CA, USA).
Statistical Analysis
Statistical tests were performed using the NCSS 2001 software
package (Kaysville, UT). Bonferroni corrections were performed
to minimize type I errors in multiple pair-wise comparisons (Rice,
1989). We used parametric statistics because the data generally
followed a normal distribution. All values are means 6 s.e.m.,
except as indicated.
Supporting Information
Figure S1 The ETH-GeneSwitch driver directed transgene
expression specifically to the Inka cells. The image is a 2D
confocal z-series projection of a larva expressing UAS-mCD8::GFP
(FBti0012685) under the control of ETH-GeneSwitch. The larva was
raised on food containing RU486. Expression of mCD8::GFP was
limited to the Inka cells. The cells in tracheal metameres (TM) 1
and 4–9 on one side are labeled with arrows. The additional signal
in the gut was due to yellowish autofluoresence. Bar = 200 mM.
(TIF)
Figure S2 EcR-B2-E9K rescued ETH protein expression and
permitted ETH secretion. (A) In TM5, ETH protein expression in
Inka cells expressing the dominant negative EcR-B1-F645A
isoform was rescued by co-expression of EcR-B2-E9K but not
wild-type EcR-B2. Means with the same lower case letters (TM5)
were not significantly different (p.0.05). All larvae were fed
RU486 and were dissected at ,12 hr after ecdysis to the third
instar. One-way ANOVAs (TM5, p= 0.004955; TM8, p= 0.125)
were performed with Bonferroni (all-pairwise) multiple compari-
son post-hoc tests (n = 4–8). (B) In Inka cells expressing the
dominant negative EcR-B1-F645A isoform, a reduction in ETH
immunostaining consistent with ETH secretion was observed
following rescue by EcR-B2 and EcR-B2-E9K. All animals were
fed RU486 as larvae and were dissected either 9 hr after puparium
formation (‘‘pre-HE’’) or 30 min after head eversion (‘‘post-HE’’).
Head eversion (pupal ecdysis) occurs at approximately 12–13.5 hr
after puparium formation [33]. Control animals had the same
genotype as the EcR-B2 rescue animals, but were not fed RU486.
One-way ANOVAs (TM5, p= 0.005087; TM8, p= 0.007636)
were performed with Bonferroni (all-pairwise) multiple compari-
son post-hoc tests (n = 6). Note: Different developmental stages
and confocal imaging settings were used for the experiments in
panel (A) versus in (B), and the relative protein levels cannot be
directly compared between these experiments.
(TIF)
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